KLKB1 and colitis: After treatment with DSS, Klkb1−/− mice showed a significant decrease in body weight loss and DAI (Figures 8A,B), and exhibited significant attenuation in colon shortening and destructive colitis (Figures 8C,D) compared to Klkb1+/+ mice.